Articles On Medadvisor (ASX:MDR)

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

Summary The ASX 200 dropped by 10.50 points or 0.14% to 7,406.90 by lunch. Barring materials, all sectors were trading in red, while utilities and tech declined the most. Origin Energy was the top laggard on ASX, falling nearly 9%. N...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

The MedAdvisor Ltd (ASX: MDR) share price is on the rise today after the company announced a US business update. The medication management platform provider’s shares are currently up 12% to 32.5 cents. Why did the MedAdvisor share price...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

It’s Thursday and who knew buying an Xbox was a bargain? Here’s the news from around the world.   Trump’s Facebook comeback? While Facebook’s independent oversight board may have decided to back the company’s January suspension of former Pr...

The ASX 200 managed to hold on to its lunchtime gains today, finishing the day higher by 0.43 per cent. Health care and Information Tech were the best and worst performing sectors respectively. Geospatial tech company Nearmap (ASX:NEA) rose...

On a day the ASX finished nearly 0.5 per cent up, tech stood alone in the red losing more than 2 per cent. The ASX 200 closed 0.56 per cent up at 7,068 points and the ASX Emerging Companies Index rose 0.41 per cent closing at 2,111 points....

Stockhead taps an extensive list of experts in Money Talks, our regular drill down into the stocks investors are looking at right now. Today, we hear from Justin Rosenberg, executive director of corporate finance at Gleneagle Securities.  ...

The MedAdvisor Ltd (ASX: MDR) share price is soaring today after the company announced an extension of a health program deal. In early afternoon trade, the medication management platform provider’s shares are swapping hands for 33.5 cents,...

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on form and pushing higher again. At the time of writing, the benchmark index is up 0.3% to 6,799.7 points. Four ASX shares that are climbing more than most today are listed...

Global stock markets dipped Stock markets dipped globally on fears over a potential third lockdown in Europe. Wall Street has seesawed throughout the week, as European shares hit a two-week low. Dow Jones was down 0.01%, S&P 500 fell by...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

G’day gang, it’s Thursday already. Here’s your local and global tech news. Don’t forget to tune in for the Startup Daily show on Ausbiz.com.au  every weekday, 2-2.45pm. Watch online, download the ausbiz app or via 7Plus. Square buys BTC Ja...

Summary MedAdvisor has experienced significant growth in the US after an acquisition, which was completed in November.  It is also entering new markets to drive the expansion of its platform.  MedAdvisor (ASX:MDR) shares closed nea...

Summary In 2020, the stock market stayed highly volatile due to the negative impact of the coronavirus pandemic.  However, the healthcare sector remained relatively stable and managed to give good returns to the investors. CogState, P...

Future prospects of the health booking platform – 1st Group – with some new opportunities on the horizon By Tim Boreham How a founder’s ASX-listed healthcare platform saved his own life Health platform founder Klaus Bartosch offers an unusu...

The MedAdvisor Ltd (ASX: MDR) share price has been a positive performer on Monday morning. At the time of writing, the medication management platform provider’s shares are up 2.5% to 40 cents. Why is the MedAdvisor share price pushing high...

The MedAdvisor Ltd (ASX: MDR) share price is up 8.22% to 40 cents after the medtech company released second-half results for its newly acquired Adheris subsidiary. The results show that Adheris is performing stronger than expected.  Wha...

Earlier this week I looked at a couple of healthcare shares that have been tipped as potential market-beaters. Today, I thought I would take a look at the healthcare sector again, but this time at the small end of town. Two small cap healt...

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and is pushing higher. At the time of writing, the benchmark index is up 0.2% to 6,498.3 points. Four shares that have failed to follow the marke...

The MedAdvisor Ltd (ASX: MDR) share price was a strong performer on Friday. The medication management platform provider’s shares were up as much as 9% to 42.5 cents at one stage. The MedAdvisor share price ultimately ended the day 6.5% hig...

Medical software group MedAdvisor (ASX: MDR) has come to the diagnosis that a discount may work better for its recently launched capital raise to acquire US-based Adheris Health. Earlier this week the Melbourne-based group launched a $45...

The MedAdvisor Ltd (ASX: MDR) share price will be one to watch later this week when it returns from its trading halt. Why is Medadvistor in a trading halt? This afternoon the medication management platform provider requested a trading halt...

Medical software group MedAdvisor (ASX: MDR) is prepared to massively dilute current shareholdings to secure the funds for a $49 million acquisition of Adheris LLC. The Melbourne-based company has entered into a binding agreement to acqui...

Shares in ASX-listed MedAdvisor have been placed in a trading halt today with the health-tech venture announcing plans to acquire US-based medication adherence company Adheris for US$34.5 million (AU$49m), while also raising AU$45 million t...

If you’re interested in gaining exposure to the small cap side of the market, I think it could be worth looking for options in the healthcare sector. In this sector there are a number of companies that are benefiting from favourable tailwi...

Medical technology is a broad field covering areas like biotechnology, pharmaceuticals, and information technology. Advancements in medical technology improve the way doctors diagnose and treat patients, leading to better health outcomes....

Fortunes were to be made in ASX health stocks during March and April as investors looked for salvation from the COVID-19 pandemic fears rocking markets. However, once the two biggest health stocks Resmed (ASX:RMD) and CSL (ASX:CSL) are take...

The Australian share market is home to a number of world class healthcare companies such as Ramsay Health Care Limited (ASX: RHC) and Cochlear Limited (ASX: COH). While I believe both companies still have a lot of growth left in them, the...

Right now, I believe that are a number of small cap ASX shares that have the potential to grow into much larger entities in the future. Three small cap shares which I feel would be worth keeping a close eye on are listed below. Here’s why...

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

Due to new technologies and favourable industry tailwinds, I think there are a number of small cap ASX healthcare shares which have the potential to grow materially over the next 10 years. Three small cap healthcare shares to add to your w...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Cochlear’s...

One area of the market that I think is a good place to look for buy and hold options is the small end of the healthcare sector. I think here you’ll find a number of companies that have the potential to grow significantly in the future than...

When it comes to investing in world class healthcare companies, the Australian share market is home to a number of them such as Cochlear Limited (ASX: COH) and Ramsay Health Care Limited (ASX: RHC). While these blue chip shares certainly h...

Shares in MedAdvisor Limited (ASX:MDR), traded up to 10% higher on Monday after the company announced that its telehealth and on-demand home delivery features are now live. The company is a prominent technology partner used by about 60% of...

Global funding for telehealth companies surged in the March quarter as investors jumped on what will clearly be a trend for 2020. A total of $US788m ($1.3bn) was invested into this sector making it the top funded digital health segment in t...

      Working from home was once an office perk. Now, after a month of everyone being forced to do it in a bid to flatten the curve on coronavirus, plenty of people are realising how much they miss the routine of getting up and heading to...

Following the excellent analysis of how volatile March 2020 was for the Dow Jones Industrial Average by Nick Maggiulli from Of Dollars & Data, I decided to take Nick’s methodology and see what it would reveal about the S&P/ASX Emerg...

2020 was looking good for many companies but COVID-19 changed all that. Some have needed capital to keep going and one was sleep apnoea mouthguard maker Somnomed (ASX:SOM). In February, the company reported solid revenue and operating profi...

Digital medication management company MedAdvisor (ASX: MDR) will add a telehealth service to its online platform to help protect Australians from widespread impacts of the coronavirus pandemic. The company will extend the GP Link feature wi...

The MedAdvisor Ltd (ASX: MDR) share price has been on fire on Tuesday morning. At the time of writing the medical technology company’s shares are up 10% to 44 cents. Why is the MedAdvisor share price rocketing higher? Investors have been b...

 ASX-listed MedAdvisor has fast-tracked plans to launch an “Uber” for pharmacy delivery services as part of the company’s response to the COVID-19 crisis.  MedAdvisor (ASX: MDR) shares have soared more than 25% today on the news to close at...

The developer of a home delivery service for prescription medicines hopes to ease the burden placed on pharmacies and assist those most vulnerable to Covid-19. Listed digital medication management company MedAdvisor (ASX: MDR) has fast-tr...

Australian-based MedAdvisor (ASX: MDR) will begin offering home delivery to customers as a way of reducing pharmacy to patient contact in a COVID-19 environment. The company has announced it will proceed with Phase 1 of its service to help...